ClinicalTrials.Veeva

Menu

The Association Between Overweight and Oocyte Diameter in Women Undergoing Vitro Fertilization

H

Hillel Yaffe Medical Center

Status

Unknown

Conditions

Infertility
Obesity

Treatments

Other: Oocyte Measurement

Study type

Observational

Funder types

Other

Identifiers

NCT01672931
0034-12 HYMC

Details and patient eligibility

About

We believe that there is an association between BMI and oocyte diameter in women undergoing IVF treatments. We plan to measure the oocyte diameter in 2 groups of women undergoing IVF. One group will have BMI 20-25 and the other group will have BMI above 30.

Enrollment

60 estimated patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • IVF treated patients
  • BMI between 20-25 or over 30

Exclusion criteria

  • Everyone else

Trial design

60 participants in 2 patient groups

BMI over 30
Description:
Women undergoing IVF with BMI over 30
Treatment:
Other: Oocyte Measurement
BMI 20-25
Description:
Women undergoing IVF treatments with BMI between 20-25
Treatment:
Other: Oocyte Measurement

Trial contacts and locations

1

Loading...

Central trial contact

Gai Shrem, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems